Items tagged with Research and development

Appeal to develop VXc-486 for tuberculosis (post with simple image)

Advocates urge Vertex to assure the timely and responsible development of drug candidate VXc-486 for tuberculosis.

The FDA’s concession conundrum (post with simple image)

Can regulatory incentives promote responsible TB drug development?

The 21st Century Cures Act’s “pathway to crisis” in drug safety (post with simple image)

Federal legislation promises a substantial increase in NIH funding — at the expense of a significantly weakened FDA.

Tuberculosis research funding crisis imperils elimination goal (post with simple image)

TAG's annual Report on Tuberculosis Research Funding Trends shows that worldwide funding for tuberculosis research fell $1.3 billion short of global targets in 2014.

Global pharmaceutical industry calls on governments to work with them to beat the rising threat of antimicrobial resistance (post with simple image)

In a joint declaration more than 80 leading international pharmaceutical, generics, diagnostics and biotechnology companies, as well as key industry bodies, call on governments and industry to work in parallel in taking comprehensive action against antimicrobial resistance.

UNITAID study looks at delinking cost of R&D from price of medicines (post with simple image)

The study explores how to separate the costs of research and development (R&D) from the future market price of vaccines, medicines and diagnostics – a concept known as “delinkage”.

UAEM calls for a people-centered approach to biomedical R&D (post with simple image)

Universities Allied for Essential Medicines (UAEM) launches Re:Route, a mapping of alternative biomedical research and development (R&D) initiatives.

Lives on the Edge: Time to align medical research and development with people’s health needs (post with simple image)

Médecins Sans Frontières (MSF) released a report that outlines shortcomings of the current system for new drug development. The report highlights resulting access barriers and proposes policy solutions.

Tackling drug-resistant infections globally: final report and recommendations (post with simple image)

The Review on Antimicrobial Resistance released its final report and recommendations warning that antimicrobial-resistant infections such as drug-resistant tuberculosis could kill 10 million people a year by 2050 without an urgent expansion of resources and funds.

The time is now: how we can start taking action on TB R&D (post with simple image)

Treatment Action Group released a new resource, Breathing Life into Flatlined U.S. Government Funding for Tuberculosis Research: FY 2017–2020 Allocations and Recommendation, to spark and support ongoing advocacy on TB R&D.

Page 15 of 18 · Total posts: 0

←First 14 15 16 Last→